Vipin Suri

4.2k total citations · 1 hit paper
26 papers, 2.3k citations indexed

About

Vipin Suri is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Oncology. According to data from OpenAlex, Vipin Suri has authored 26 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Vipin Suri's work include Hormonal Regulation and Hypertension (8 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Vipin Suri is often cited by papers focused on Hormonal Regulation and Hypertension (8 papers), Immune Cell Function and Interaction (5 papers) and CAR-T cell therapy research (4 papers). Vipin Suri collaborates with scholars based in United States, Canada and France. Vipin Suri's co-authors include Michael Rosbash, Joan E. Rutila, Jeffrey C. Hall, W. Venus So, James F. Tobin, Nello Mainolfi, Mark Manfredi, Joshua D. Rabinowitz, Gregory S. Ducker and James L. Ellis and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Vipin Suri

26 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CYCLE Is a Second bHLH-PAS Clock Protein Essential for Circadian Rhythmicity and Transcription of Drosophila period and timeless

1998 538 citations Joan E. Rutila, Vipin Suri et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vipin Suri United States	19	738	706	500	489	298	26	2.3k
Henry Juguilon United States	9	2.3k 3.2×	632 0.9×	210 0.4×	313 0.6×	1.1k 3.7×	12	4.2k
Hiroshi Shimeno Japan	30	1.6k 2.2×	336 0.5×	187 0.4×	179 0.4×	484 1.6×	113	3.7k
Shinji Soeda Japan	29	1.3k 1.7×	334 0.5×	172 0.3×	151 0.3×	412 1.4×	81	3.1k
Sean M. Armour United States	14	2.1k 2.9×	342 0.5×	175 0.3×	241 0.5×	910 3.1×	18	4.2k
Paola Fabrizio United States	23	2.7k 3.7×	290 0.4×	379 0.8×	218 0.4×	838 2.8×	36	4.1k
Kelly Suino-Powell United States	25	1.9k 2.5×	192 0.3×	316 0.6×	269 0.6×	456 1.5×	33	3.5k
Lucrezia Guida Italy	38	1.2k 1.7×	155 0.2×	366 0.7×	202 0.4×	463 1.6×	91	4.0k
Kayo Yasuda Japan	27	1.9k 2.5×	265 0.4×	161 0.3×	203 0.4×	763 2.6×	63	3.5k
Lei Yin United States	27	913 1.2×	511 0.7×	103 0.2×	98 0.2×	473 1.6×	44	2.1k
Nancy J. Linford United States	18	1.5k 2.0×	209 0.3×	98 0.2×	472 1.0×	778 2.6×	20	2.8k

Countries citing papers authored by Vipin Suri

Since Specialization

Citations

This map shows the geographic impact of Vipin Suri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vipin Suri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vipin Suri more than expected).

Fields of papers citing papers by Vipin Suri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vipin Suri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vipin Suri. The network helps show where Vipin Suri may publish in the future.

Co-authorship network of co-authors of Vipin Suri

This figure shows the co-authorship network connecting the top 25 collaborators of Vipin Suri. A scholar is included among the top collaborators of Vipin Suri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vipin Suri. Vipin Suri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muniraj, Nethaji, et al.. (2023). Abstract 3191: Genetically modified TGF-β dominant negative receptor and IL15 enhance Natural Killer (NK) cell mediated cytolytic activity in glioblastoma. Cancer Research. 83(7_Supplement). 3191–3191. 1 indexed citations

Hamza, Bashar, Ángela Núñez, Henry Gómez, et al.. (2023). Abstract 2904: CAT-179, an allogeneic NK cell product expressing HER2-CAR, IL-15 and TGFβ dominant negative receptor, durably regresses HER2-expressing xenograft tumors in mice. Cancer Research. 83(7_Supplement). 2904–2904. 1 indexed citations

Ducker, Gregory S., Leah K. Billingham, Carlos A. Martínez, et al.. (2019). Serine Metabolism Supports Macrophage IL-1β Production. Cell Metabolism. 29(4). 1003–1011.e4. 251 indexed citations

Ducker, Gregory S., Jonathan M. Ghergurovich, Nello Mainolfi, et al.. (2017). Human SHMT inhibitors reveal defective glycine import as a targetable metabolic vulnerability of diffuse large B-cell lymphoma. Proceedings of the National Academy of Sciences. 114(43). 11404–11409. 179 indexed citations

Opal, Steven M., James L. Ellis, Vipin Suri, et al.. (2015). PHARMACOLOGICAL SIRT1 ACTIVATION IMPROVES MORTALITY AND MARKEDLY ALTERS TRANSCRIPTIONAL PROFILES THAT ACCOMPANY EXPERIMENTAL SEPSIS. Shock. 45(4). 411–418. 44 indexed citations

Miranda, Melroy, Lambertus J. van Tits, Christine Lohmann, et al.. (2014). The Sirt1 activator SRT3025 provides atheroprotection in Apoe−/− mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expression. European Heart Journal. 36(1). 51–59. 123 indexed citations

Suri, Vipin, Cloud P. Paweletz, & Chunaram Choudhary. (2013). Proteomics Meets Cellular Signaling: Exploring Post-translational Modifications by Mass Spectrometry. Science. 340(6131). 499–499. 1 indexed citations

Yang, Hongying, Wei Zhang, Heng Pan, et al.. (2012). SIRT1 Activators Suppress Inflammatory Responses through Promotion of p65 Deacetylation and Inhibition of NF-κB Activity. PLoS ONE. 7(9). e46364–e46364. 297 indexed citations

Wang, Mengmeng, Xianbin Tian, Louis Leung, et al.. (2011). Comparative Pharmacokinetics and Metabolism Studies in Lean and Diet- Induced Obese Mice: An Animal Efficacy Model for 11β -Hydroxysteroid Dehydrogenase Type 1 (11β -HSD1) Inhibitors. Drug Metabolism Letters. 5(1). 55–63. 6 indexed citations

10.

Cao, Jingsong, Yingjiang Zhou, Xinyi Huang, et al.. (2011). Targeting Acyl-CoA:Diacylglycerol Acyltransferase 1 (DGAT1) with Small Molecule Inhibitors for the Treatment of Metabolic Diseases. Journal of Biological Chemistry. 286(48). 41838–41851. 119 indexed citations

11.

Zhang, Yanling, Xiaotian Zhong, Yuanhong Li, et al.. (2008). H6PDH interacts directly with 11β-HSD1: Implications for determining the directionality of glucocorticoid catalysis. Archives of Biochemistry and Biophysics. 483(1). 45–54. 31 indexed citations

12.

Xiang, Jason, Zhao‐Kui Wan, Huan‐Qiu Li, et al.. (2008). Piperazine Sulfonamides as Potent, Selective, and Orally Available 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors with Efficacy in the Rat Cortisone-Induced Hyperinsulinemia Model. Journal of Medicinal Chemistry. 51(14). 4068–4071. 26 indexed citations

13.

Xiang, Jason, Manus Ipek, Vipin Suri, et al.. (2007). β-Keto sulfones as inhibitors of 11β-hydroxysteroid dehydrogenase type I and the mechanism of action. Bioorganic & Medicinal Chemistry. 15(13). 4396–4405. 98 indexed citations

14.

Li, G., et al.. (2007). Role of SNAREs and H+-ATPase in the targeting of proton pump-coated vesicles to collecting duct cell apical membrane. Kidney International. 72(11). 1310–1315. 23 indexed citations

15.

Erbe, David V., Yanling Zhang, Vipin Suri, et al.. (2006). Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists. Vascular Pharmacology. 45(3). 154–162. 122 indexed citations

16.

Xiang, Jason, Manus Ipek, Vipin Suri, et al.. (2005). Synthesis and biological evaluation of sulfonamidooxazoles and β-keto sulfones: selective inhibitors of 11β-hydroxysteroid dehydrogenase type I. Bioorganic & Medicinal Chemistry Letters. 15(11). 2865–2869. 72 indexed citations

17.

Suri, Vipin, et al.. (2000). Two NoveldoubletimeMutants Alter Circadian Properties and Eliminate the Delay between RNA and Protein inDrosophila. Journal of Neuroscience. 20(20). 7547–7555. 81 indexed citations

18.

Suri, Vipin. (1999). TIMELESS-dependent positive and negative autoregulation in the Drosophila circadian clock. The EMBO Journal. 18(3). 675–686. 47 indexed citations

19.

Rutila, Joan E., et al.. (1998). CYCLE Is a Second bHLH-PAS Clock Protein Essential for Circadian Rhythmicity and Transcription of Drosophila period and timeless. Cell. 93(5). 805–814. 538 indexed citations breakdown →

20.

Suri, Vipin, et al.. (1998). Evidence that the TIM Light Response Is Relevant to Light-Induced Phase Shifts in Drosophila melanogaster. Neuron. 21(1). 225–234. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact